韩国三级大全久久网站,99久久久无码国产精品性,欧美日本一区二区三区免费

WCK-4234 sodium

NMR下載 COA and HPLC MSDS下載
names：
sodium (2S,5R)-2-cyano-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl sulfate
CAS號(hào)：
1804915-68-1
MDL Number：
MF(分子式)： C7H8N3NaO5S MW(分子量)： 269.2068
EINECS: Reaxys Number:
Pubchem ID: Brand:BIOFOUNT

貨品編碼	規(guī)格	純度	價(jià)格 (￥)	現(xiàn)價(jià)(￥)	特價(jià)(￥)	庫(kù)存描述	數(shù)量	總計(jì) (￥)

大包裝詢(xún)價(jià) 提供各種包裝，敬請(qǐng)垂詢(xún)
收藏商品商品點(diǎn)評(píng) 加入購(gòu)物車(chē) 立即購(gòu)買(mǎi)

快速詢(xún)價(jià)

收起

你想詢(xún)價(jià)的產(chǎn)品

*產(chǎn)品名稱(chēng)：

CAS號(hào)：

產(chǎn)品編號(hào)：

需求描述：

請(qǐng)準(zhǔn)確填寫(xiě)您的聯(lián)系方式，以便為您提供最好的服務(wù)。

*公司名稱(chēng)：

*電子郵箱：

聯(lián)系人：

*電話(huà)：

*驗(yàn)證碼：

詢(xún)價(jià)

中文別名	sodium (2S,5R)-2-cyano-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl sulfate
英文別名	WCK-4234; WCK 4234; WCK4234.
CAS號(hào)	1804915-68-1
Inchi	InChI=1S/C7H9N3O5S.Na/c8-3-5-1-2-6-4-9(5)7(11)10(6)15-16(12,13)14;/h5-6H,1-2,4H2,(H,12,13,14);/q;+1/p-1/t5-,6+;/m0./s1
InchiKey	RYJWKSOILDDAHI-RIHPBJNCSA-M
分子式 Formula	C7H8N3NaO5S
分子量 Molecular Weight	269.2068
溶解度Solubility
性狀	Solid powder
儲(chǔ)藏條件 Storage conditions	Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).

產(chǎn)品說(shuō)明	WCK-4234 sodium(CAS:1804915-68-1 ):僅限應(yīng)用于工業(yè)或者科學(xué)研究過(guò)程中非醫(yī)療目的，不應(yīng)用于人類(lèi)或動(dòng)物的臨床診斷以及治過(guò)程療，該產(chǎn)品非藥用，非食用。
Introduction	WCK-4234 is a potent β-lactamase inhibitor. WCK-4234 inhibited class A, C and D β-lactamases with unprecedented k2/K values against OXA carbapenemases. WCK-4234 inhibited class A, C and D β-lactamases with unprecedented k2/K values against OXA carbapenemases. WCK-4234 formed highly stable acyl-complexes via mass spectrometry. WCK-4234 is a novel β-lactamase inhibitor that demonstate potent cross-class inhibition and clinical studies targeting MDR infections are warranted.
Application1
Application2
Application3

警示圖
危險(xiǎn)性	Warning
危險(xiǎn)性警示
安全聲明
安全防護(hù)
備注

[1]Papp-Wallace KM, Nguyen NQ, Jacobs MR, Bethel CR, Barnes MD, Kumar V,Bajaksouzian S, Rudin SD, Rather PN, Bhavsar S, Ravikumar T, Deshpande PK, PatilV, Yeole R, Bhagwat SS, Patel MV, van den Akker F, Bonomo RA. Strategicapproaches to overcome resistance against Gram negative pathogens usingβ-lactamase inhibitors and β-lactam enhancers: The activity of three noveldiazabicyclooctanes, WCK 5153, zidebactam (WCK 5107), and WCK 4234. J Med Chem.2018 Apr 7. doi: 10.1021/acs.jmedchem.8b0009[1][Epub ahead of print] PubMed PMID:29627985.

[2]Moya B, Barcelo IM, Bhagwat S, Patel M, Bou G, Papp-Wallace KM, Bonomo RA,Oliver A. Potent β-Lactam Enhancer Activity of Zidebactam and WCK 5153 againstAcinetobacter baumannii, Including Carbapenemase-Producing Clinical Isolates.Antimicrob Agents Chemother. 2017 Oct 24;61(11). pii: e01238-17. doi:10.1128/AAC.01238-17. Print 2017 Nov. PubMed PMID: 28848013; PubMed CentralPMCID: PMC5655067.

[3] Moya B, Barcelo IM, Bhagwat S, Patel M, Bou G, Papp-Wallace KM, Bonomo RA,Oliver A. WCK 5107 (Zidebactam) and WCK 5153 Are Novel Inhibitors of PBP2 ShowingPotent "β-Lactam Enhancer" Activity against Pseudomonas aeruginosa, IncludingMultidrug-Resistant Metallo-β-Lactamase-Producing High-Risk Clones. AntimicrobAgents Chemother. 2017 May 24;61(6). pii: e02529-16. doi: 10.1128/AAC.02529-16.Print 2017 Jun. PubMed PMID: 28289035; PubMed Central PMCID: PMC5444176.

對(duì)不起，暫無(wú)產(chǎn)品評(píng)價(jià)！

MSDS

SDS 1.0 中文

展開(kāi)

SDS 1.0 英文

展開(kāi)